Annual Cash & Cash Equivalents
$15.74 M
-$24.83 M-61.20%
31 December 2022
Summary:
Better Therapeutics annual cash & cash equivalents is currently $15.74 million, with the most recent change of -$24.83 million (-61.20%) on 31 December 2022. During the last 3 years, it has risen by +$15.62 million (+12696.75%). BTTX annual cash & cash equivalents is now -61.20% below its all-time high of $40.57 million, reached on 31 December 2021.BTTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.60 M
+$402.00 K+6.49%
30 September 2023
Summary:
Better Therapeutics quarterly cash and cash equivalents is currently $6.60 million, with the most recent change of +$402.00 thousand (+6.49%) on 30 September 2023. BTTX quarterly cash and cash equivalents is now -83.74% below its all-time high of $40.57 million, reached on 31 December 2021.BTTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BTTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +10000.0% | +2555.1% |
| 5 y5 years | - | - |
BTTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.2% | >+9999.0% | -83.7% | +2555.1% |
| 5 y | 5 years | -61.2% | >+9999.0% | -83.7% | +2555.1% |
| alltime | all time | -61.2% | >+9999.0% | -83.7% | +2555.1% |
Better Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $6.60 M(+6.5%) |
| June 2023 | - | $6.20 M(+2.1%) |
| Mar 2023 | - | $6.07 M(-61.4%) |
| Dec 2022 | $15.74 M | $15.74 M(-29.4%) |
| Sept 2022 | - | $22.30 M(-24.9%) |
| June 2022 | - | $29.68 M(-6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $31.67 M(-21.9%) |
| Dec 2021 | $40.57 M(>+9900.0%) | $40.57 M(>+9900.0%) |
| Sept 2021 | - | $248.50 K(-88.3%) |
| June 2021 | - | $2.12 M |
| Dec 2020 | $123.00 K(-83.8%) | - |
| Dec 2019 | $757.00 K | - |
FAQ
- What is Better Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Better Therapeutics?
- What is Better Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Better Therapeutics?
What is Better Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BTTX is $15.74 M
What is the all time high annual cash & cash equivalents for Better Therapeutics?
Better Therapeutics all-time high annual cash & cash equivalents is $40.57 M
What is Better Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BTTX is $6.60 M
What is the all time high quarterly cash and cash equivalents for Better Therapeutics?
Better Therapeutics all-time high quarterly cash and cash equivalents is $40.57 M